Alternative splicing of the human MUC2 gene☆
Section snippets
Cell lines
Human colon cancer cell line HM7 is a derivative of the colon adenocarcinoma line LS174T (ATCC CL188) [22] and has been described previously [8], [23], [24]. Cell lines HM7-F6, HM7-B10, HM7-C5, HM7-E8, HM7-E2, and HM7-E3 are subclonal derivatives of HM7 that express different relative levels of human MUC2 protein. Low passage aliquots were maintained in a 5% CO2 environment at 37 °C in Dulbecco’s modified Eagle medium (Life Technologies, Rockville, MD), with 10 % fetal bovine serum, penicillin
Variation in expression of MUC2 protein in human colon cancer cell lines
HM7 is a derivative of the LS174T colon cancer cell line and has been extensively characterized [8], [23], [24]. Previous results indicate that a predominant form of mucin produced in HM7 cells is MUC2 intestinal mucin [6]. Derivatives of the HM7 cell line (HM7-F6, HM7-B10, HM7-C5, HM7-E8, HM7-E2, and HM7-E3) were isolated by limiting dilution and assayed for relative expression with anti-MUC2TR2 (monoclonal antibody CCP58) against a non-O-glycosylated peptide sequence within the MUC2 TR2
Discussion
Inherent difficulties in the resolution of high molecular weight proteins make it difficult to conclude whether MUC2 is expressed as a single apoprotein. This uncertainty is recapitulated at the mRNA level. The majority of published Northern blot hybridization reports indicate that MUC2 mRNA resolves as either a disperse signal 3–15 kb in size [6], [12], [32] or several wide bands within the same range [5], [33]. Possible explanations for this have included alternative splicing, alternate
Acknowledgements
This work was supported by National Cancer Institute Grant R01CA69480. The authors acknowledge Neil W. Toribara for providing unpublished MUC2 DNA sequences and thank Chris Yunker for excellent technical assistance.
References (51)
- et al.
Int. J. Biochem. Cell. Biol.
(1998) - et al.
J. Biol. Chem.
(1999) - et al.
J. Biol. Chem.
(1989) - et al.
Biochem. Biophys. Res. Commun.
(1994) - et al.
Gastroenterology
(1999) - et al.
Gastroenterology
(2002) - et al.
J. Biol. Chem.
(1994) - et al.
Eur. J. Cancer.
(1997) - et al.
J. Biol. Chem.
(1990) - et al.
Biochem. Biophys. Res.Commun.
(1999)
Biochem. Biophys. Res. Commun.
J. Biol. Chem.
J. Biol. Chem.
Gastroenterology
J. Mol. Biol.
Cell
J. Biol. Chem.
J. Biol. Chem.
J. Biol. Chem.
Biochem. Biophys. Res. Commun.
Biochem. Biophys. Res. Commun.
J. Dekker. Gut.
Int. J. Cancer
J. Clin. Invest.
J. Biol. Chem.
Cited by (16)
Methylmercury exposure alters RNA splicing in human neuroblastoma SK-N-SH cells: Implications from proteomic and post-transcriptional responses
2018, Environmental PollutionCitation Excerpt :For example, the misregulation of alternative splicing of survival motor neuron 2 exon 7 was shown to cause spinal muscular atrophy, which is a common neurodegenerative disease (Kashima and Manley, 2003). Misregulation of several genes (CD44 and MUC2) was found to correlate with human colorectal tumors (Finn et al., 1994; Gardina et al., 2006; Sternberg et al., 2004). Numerous genomic, transcriptomic, and proteomic-based technologies were applied to assess the expression profiles of genes, RNAs, and proteins in response to heavy metal exposure using various tissues and cell lines.
Comparative Animal Mucomics: Inspiration for Functional Materials from Ubiquitous and Understudied Biopolymers
2020, ACS Biomaterials Science and EngineeringIN-VIVO REPLICATION OF CYPRINID HERPESVIRUS-3 IN GOLDFISH
2019, Assiut Veterinary Medical Journal (Egypt)Genetic variants of mucins: Unexplored conundrum
2017, CarcinogenesisUtility of bromelain and N-acetylcysteine in treatment of peritoneal dissemination of gastrointestinal mucin-producing malignancies
2016, Utility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing MalignanciesApplications of nanosystems to anticancer drug therapy (Part II. dendrimers, micelles, lipid-based nanosystems)
2014, Recent Patents on Anti-Cancer Drug Discovery